The ultimate test of the viability of the product is whether significant numbers of people will see enough of an advantage to pay for it. No investor will take the leap unless the size of that market opportunity can be quantified.
Read "Funding lack for oral drip device frustrates inventor" article at stuff.co.nz >>
Comments
Post has no comments.Post a Comment